Welcome to your Weekly Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
Omega Healthcare and Microsoft Enhance AI for RCM
Omega Healthcare, the industry leader in revenue cycle management (RCM), has strengthened its partnership with Microsoft to enhance its AI-powered capabilities. Bringing on board more than 20 sophisticated generative and agentic AI tools through Microsoft Azure AI Foundry in its Omega Digital Platform (ODP), the organization hopes to automate and enhance key healthcare financial processes—such as claims correspondence, appeal filings, denial management, and call‑center assistance—resulting in better accuracy, compliance, and profitability for healthcare providers.
Cardinal Health Launches One Voice for Pharmacy Advocacy
Cardinal Health announced the launch of the Cardinal Health One Voice Initiative for pharmacy advocacy, which provides direct financial assistance to state pharmacy associations for the purpose of supporting independent pharmacists’ advocacy efforts.
Nymbl Appoints Josh Davidson as Chief Technology Officer
Nymbl, a healthcare technology company that helps DMEPOS providers with practice management, has named Josh Davidson as its new Chief Technology Officer.
Lyra Health Acquires Bend Health, Expanding Whole Family Mental Health Care
Lyra Health, a top provider of mental health benefits for employers, has bought Bend Health Inc. , which is into the sector of mental health care for kids. This move helps Lyra better support families as more children face mental, emotional, or behavioral issues.
Concord Delivers China’s First Proton Therapy for Eye Cancer
Concord Healthcare Group Co, a subsidiary of Concord Medical Services Holdings Limited , which subsidiary is listed on the Main Board of The Stock Exchange of Hong Kong Limited under the stock code 2453.HK, announced that on July 11, 2025, Guangzhou Concord Cancer Center, a subsidiary of Concord Healthcare, successfully completed the first proton therapy treatment in China for a patient with choroidal malignant melanoma.
Automated Prescription Medication Safety: Xact Labs Receives Groundbreaking Patent
Xact Laboratories, a Biotech innovator in evidence-based medication guidance, has received a landmark United States Patent No.: US 12,354,724 B2, issued July 8, 2025, that will revolutionize pharmacogenomic and genetic efficacy data exchange. This milestone establishes Xact Laboratories’ intellectual property rights over genetic testing data transmitted to pharmacy systems or provider electronic networks- which is a critical step toward establishing pharmacogenomics (PGx) as standard of care.
Waud Capital Partners Forms New Partnership with Experienced Healthcare Executive Bill Mixon
Waud Capital Partners, a growth-oriented middle-market private equity firm, announced that it has formalized an executive partnership with Bill Mixon to pursue a platform investment in the medical device and supply chain services market. Targeted sub-sectors of focus will include but are not limited to home distribution, other value-add specialty distribution, outsourced provider equipment services, and chronic care and population health management offerings that deliver value to supply chain channel partners. Waud Capital anticipates investing over $100 million of equity capital to support the initiative.
Human Longevity Pledges $1Million to Fight Ovarian Cancer
Human Longevity, Inc., a global leader in precision medicine and proactive healthcare, announced the expansion of its $1 million cancer prevention pledge — now focused on late-stage ovarian cancer. Reflecting HLI’s unwavering belief in early detection and the power of precision diagnostics, this bold initiative will offer up to $1 million in treatment and clinical support for any qualified member diagnosed with late-stage ovarian cancer while actively participating in HLI’s Executive Health Program or affiliated 100+ Longevity Programs.
Steve Wardle Joins BrainCheck as President to Scale Cognitive Care Platform
BrainCheck, a leading digital cognitive assessment and care platform, announced that Steve Wardle, former co-founder and CEO of Iris Healthcare, has joined the company as President. Wardle will lead BrainCheck’s care delivery and product development as the company expands its footprint in primary care, neurology, and value-based care environments.
CivicaScript Launches Low-Cost Cancer Drug To Make Treatment More Affordable
CivicaScript, LLC, a nonprofit company dedicated to bringing low-cost generic medicines to U.S. patients, announced the availability of its generic capecitabine. Capecitabine is a nucleoside metabolic inhibitor indicated for certain types of colorectal, breast, gastric, esophageal, gastroesophageal junction or pancreatic cancer.
To share your insights, please write to us at sudipto@intentamplify.com
